Literature DB >> 29421276

SCCA2 is a reliable biomarker for evaluating pediatric atopic dermatitis.

Mizuho Nagao1, Shinichiro Inagaki2, Toshiki Kawano3, Yoshinori Azuma4, Noriko Nomura4, Yasuhiko Noguchi4, Shoichiro Ohta5, Atsushi Kawaguchi6, Hiroshi Odajima3, Yukihiro Ohya2, Takao Fujisawa7, Kenji Izuhara8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29421276     DOI： 10.1016/j.jaci.2018.01.021

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

1.  A Serum Level of Squamous Cell Carcinoma Antigen as a Real-Time Biomarker of Atopic Dermatitis.

Authors:  Masaki Shimomura; Yuka Okura; Yutaka Takahashi; Ichiro Kobayashi
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2021-08-19       Impact factor: 0.885

Review 2.  Severe Atopic Dermatitis in Children.

Authors:  Evie Huang; Peck Y Ong
Journal:  Curr Allergy Asthma Rep       Date:  2018-05-10       Impact factor: 4.806

3.  Squamous cell carcinoma antigens are sensitive biomarkers for atopic dermatitis in children and adolescents: a cross-sectional study.

Authors:  Junya Hirayama; Takao Fujisawa; Mizuho Nagao; Yu Kuwabara; Keigo Kainuma; Yoshinori Azuma; Junya Ono; Shoichiro Ohta; Masahiro Hirayama; Kenji Izuhara
Journal:  Asia Pac Allergy       Date:  2021-10-25

Review 4.  Squamous Cell Carcinoma Antigen 2 (SCCA2, SERPINB4): An Emerging Biomarker for Skin Inflammatory Diseases.

Authors:  Kenji Izuhara; Yukie Yamaguchi; Shoichiro Ohta; Satoshi Nunomura; Yasuhiro Nanri; Yoshinori Azuma; Noriko Nomura; Yasuhiko Noguchi; Michiko Aihara
Journal:  Int J Mol Sci       Date:  2018-04-06       Impact factor: 5.923

5.  Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol.

Authors:  Takeshi Nakahara; Kenji Izuhara; Daisuke Onozuka; Satoshi Nunomura; Risa Tamagawa-Mineoka; Koji Masuda; Susumu Ichiyama; Hidehisa Saeki; Yudai Kabata; Riichiro Abe; Mamitaro Ohtsuki; Koji Kamiya; Tatsuro Okano; Tomomitsu Miyagaki; Yozo Ishiuji; Akihiko Asahina; Hiroshi Kawasaki; Keiji Tanese; Hiroshi Mitsui; Tatsuyoshi Kawamura; Takuya Takeichi; Masashi Akiyama; Emi Nishida; Akimichi Morita; Kyoko Tonomura; Yukinobu Nakagawa; Koji Sugawara; Chiharu Tateishi; Yoko Kataoka; Rai Fujimoto; Sakae Kaneko; Eishin Morita; Akio Tanaka; Michihiro Hide; Natsuko Aoki; Shigetoshi Sano; Haruna Matsuda-Hirose; Yutaka Hatano; Motoi Takenaka; Hiroyuki Murota; Norito Katoh; Masutaka Furue
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.